Phio Pharmaceuticals (PHIO) Return on Invested Capital (2017)
Phio Pharmaceuticals' Return on Invested Capital history spans 1 years, with the latest figure at 4.73% for Q4 2017.
- For Q4 2017, Return on Invested Capital changed N/A year-over-year to 4.73%; the TTM value through Dec 2017 reached 4.73%, changed N/A, while the annual FY2017 figure was 1.96%, N/A changed from the prior year.
- Return on Invested Capital reached 4.73% in Q4 2017 per PHIO's latest filing.
- In the past five years, Return on Invested Capital ranged from a high of 4.73% in Q4 2017 to a low of 4.73% in Q4 2017.